Chosen Diagnostics is pleased to announce the receipt of a $2.1 million grant from the National Institutes of Health for the completion of the group’s NECDetect prototype to identify necrotizing enterocolitis (NEC) in preterm infants and for the initiation of corresponding clinical trials.
RELATED POSTS
May 16, 2022
The Tunica-Biloxi Tribe in Marksville, La. was awarded a grant totaling $2,499,947 for internet expansion through the Department of Commerce’s National Telecommunications and Information Administration (NTIA). Read the full article...
May 14, 2022
Ignition 2.0 is a nine-week, in-person program designed to help companies commercialize their products, ending with a Demo Day at the Goodwood Library on Wednesday, May 25. All participants will...